The entire world is racing to develop a vaccine for the novel coronavirus. Multiple pharmaceutical companies, startups, and test labs are working around the globe to come up with a vaccine. One such company is a humble startup from Europe called Takis Biotech. The Italian startup has been working on a vaccine for COVID-19 and has now announced a new milestone in its journey.
Takis Biotech produces coronavirus neutralising antibodies in test animals
Takis Biotech pivoted from working on developing cancer treatments to coronavirus vaccine. It has been working on the vaccine since late January. Now, it has announced that the first injections of the DNA vaccine candidates have produced neutralising antibodies in test animals. The injections are tested against the Spike protein of the SARS-CoV-2 virus, which causes COVID-19. The next phase of trials is slated to begin this week by the startups’ manufacturing partner, Applied DNA Sciences Inc.